VIPDOMET
HIKMA
Identification
- Active ingredient (INN)
- ALOGLIPTINE BENZOATE/METFORMINE CHLORHYDRATE
- Internal code
- 14 A 375
- Country of Origin
- Algeria
- Pharmaceutical form
- Film-coated Tablet
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/60
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Used for type
II diabetes treatment.
Associated Conditions
Medically supervised and carefully used in the following cases: kidney patients; asthma; chronic lung diseases; liver problems; pancreatic infections; and gallops; vitamin B12 deficiency.
Mechanism of Action
The two globulars control blood sugar by increasing the release of substances called adenoma, discouraging the Bipetides'bacterium enzyme, and stimulating pancreas to release insulin, while the metaphorone re-responsives the body to insulin by reducing liver sugar production and intestinal absorption.
The treatment is accompanied by the expected type 2 diabetes complications, such as neurological problems, blindness, kidney damage, and problems of sexual vulnerability, and limiting the chances of strokes and heart attacks.